Abstract #3047

Effective MR Molecular Imaging of Prostate Cancer with an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

Nadia Ayat¹, Sarah Roelle¹, Songqi Gao¹, Yajuan Li¹, and Zheng-Rong Lu¹

¹Case Western Reserve University, Cleveland, OH, United States

This research highlights the potential of a targeted contrast agent specific to the extra-domain B (EDB-FN) to be utilized in the diagnosis of prostate cancer at reduced dosages. EDB-FN specific MR contrast agent MT218 produced robust tumor enhancement at dosages as low as 0.02 mmol Gd/kg.

This abstract and the presentation materials are available to members only; a login is required.

Join Here